Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Liver Diseases

  Free Subscription


Articles published in Radiology

Retrieve available abstracts of 86 articles:
HTML format



Single Articles


    December 2022
  1. SENDUR HN, Cerit MN
    Reliable Assessment of US Performance for Liver Fat Quantification.
    Radiology. 2022;305:E70.
    PubMed    


  2. WU W, Jing X, Xue GQ, Zhu XL, et al
    A Multicenter Randomized Controlled Study of Contrast-enhanced US versus US-guided Biopsy of Focal Liver Lesions.
    Radiology. 2022;305:721-728.
    PubMed     Abstract available


  3. DUAN L, Zhang B, Zheng X
    Restratification of Advanced Hepatocellular Carcinoma to Identify Patients Sensitive to Transarterial Chemoembolization.
    Radiology. 2022;305:E73.
    PubMed    


    November 2022
  4. ZHANG W, Huang C, Yin T, Miao X, et al
    Ultrasensitive US Microvessel Imaging of Hepatic Microcirculation in the Cirrhotic Rat Liver.
    Radiology. 2022 Nov 22:220739. doi: 10.1148/radiol.220739.
    PubMed     Abstract available


  5. FETZER DT, Rosado-Mendez IM, Wang M, Robbin ML, et al
    Pulse-Echo Quantitative US Biomarkers for Liver Steatosis: Toward Technical Standardization.
    Radiology. 2022;305:265-276.
    PubMed     Abstract available


  6. YOON JH
    A Placebo Effect on MRI Proton Density Fat Fraction in Nonalcoholic Steatohepatitis Trials.
    Radiology. 2022 Nov 1:222295. doi: 10.1148/radiol.222295.
    PubMed    


  7. NEDRUD MA, Chaudhry M, Middleton MS, Moylan CA, et al
    MRI Quantification of Placebo Effect in Nonalcoholic Steatohepatitis Clinical Trials.
    Radiology. 2022 Nov 1:220743. doi: 10.1148/radiol.220743.
    PubMed     Abstract available


    October 2022
  8. WEIJERS G, Munsterman ID, Thijssen JM, Kuppeveld H, et al
    Noninvasive Staging of Hepatic Steatosis Using Calibrated 2D US with Liver Biopsy as the Reference Standard.
    Radiology. 2022 Oct 18:220104. doi: 10.1148/radiol.220104.
    PubMed     Abstract available


  9. WEAR KA, Han A, Rubin JM, Gao J, et al
    US Backscatter for Liver Fat Quantification: An AIUM-RSNA QIBA Pulse-Echo Quantitative Ultrasound Initiative.
    Radiology. 2022 Oct 18:220606. doi: 10.1148/radiol.220606.
    PubMed     Abstract available


  10. KITAO A, Matsui O, Zhang Y, Ogi T, et al
    Dynamic CT and Gadoxetic Acid-enhanced MRI Characteristics of P53-mutated Hepatocellular Carcinoma.
    Radiology. 2022 Oct 11:220531. doi: 10.1148/radiol.220531.
    PubMed     Abstract available


  11. EMMONS EC, Bishay S, Du L, Krebs H, et al
    Survival and Toxicities after (90)Y Transarterial Radioembolization of Metastatic Colorectal Cancer in the RESIN Registry.
    Radiology. 2022;305:228-236.
    PubMed     Abstract available


    September 2022
  12. DUAN L, Zhang B, Zheng X
    Restratification of Advanced Hepatocellular Carcinoma to Identify Patients Sensitive to Transarterial Chemoembolization.
    Radiology. 2022 Sep 27:221149. doi: 10.1148/radiol.221149.
    PubMed    


  13. GHELFI J, Decaens T, Macek Jilkova Z
    Rat Model of Hepatocellular Carcinoma for Better Understanding Immune Effects of Transarterial Chemoembolization.
    Radiology. 2022 Sep 6:220179. doi: 10.1148/radiol.220179.
    PubMed    


  14. VALENCIA SA, Romero JA
    Limitations of a Multiparametric US Score for NASH Prediction.
    Radiology. 2022;304:E50.
    PubMed    


    August 2022
  15. XIE J, Wei X
    Cirrhosis-related Spontaneous Mesocaval Shunt.
    Radiology. 2022 Aug 23:220564. doi: 10.1148/radiol.220564.
    PubMed     Abstract available


  16. KWAG M, Choi SH, Choi SJ, Byun JH, et al
    Simplified LI-RADS for Hepatocellular Carcinoma Diagnosis at Gadoxetic Acid-enhanced MRI.
    Radiology. 2022 Aug 16:220659. doi: 10.1148/radiol.220659.
    PubMed     Abstract available


  17. CHOI SJ, Lee SS, Jung KH, Lee JB, et al
    Noncirrhotic Portal Hypertension after Trastuzumab Emtansine in HER2-positive Breast Cancer as Determined by Deep Learning-measured Spleen Volume at CT.
    Radiology. 2022 Aug 9:220536. doi: 10.1148/radiol.220536.
    PubMed     Abstract available


  18. LUQUE-CABAL M, Alvarez-Guisasola V, Rizzo-Raza S, Sales-Fernandez C, et al
    Case 304: Porphyria Cutanea Tarda.
    Radiology. 2022;304:488-492.
    PubMed     Abstract available


  19. TORKIAN P, Akhlaghpoor S
    Considerations Regarding Image-guided Treatment of Liver Hemangioma.
    Radiology. 2022;304:E45.
    PubMed    


  20. YAN Y
    Three-dimensional MR Elastography in Distinguishing Necroinflammation from Liver Fibrosis.
    Radiology. 2022;304:E43.
    PubMed    


  21. BARR RG
    US-targeted Microbubbles to Assess Liver Fibrosis.
    Radiology. 2022;304:483-484.
    PubMed    


    July 2022
  22. DUBINSKY TJ
    Evaluating Hepatic Steatosis with MRI as the Reference Standard: Different Performances of Three US Machines.
    Radiology. 2022 Jul 12:221177. doi: 10.1148/radiol.221177.
    PubMed    


  23. CASSINOTTO C, Jacq T, Anselme S, Ursic-Bedoya J, et al
    Diagnostic Performance of Attenuation to Stage Liver Steatosis with MRI Proton Density Fat Fraction as Reference: A Prospective Comparison of Three US Machines.
    Radiology. 2022 Jul 12:212846. doi: 10.1148/radiol.212846.
    PubMed     Abstract available


    June 2022
  24. JANG JK, Lee ES, Seo JW, Kim YR, et al
    Two-dimensional Shear-Wave Elastography and US Attenuation Imaging for Nonalcoholic Steatohepatitis Diagnosis: A Cross-sectional, Multicenter Study.
    Radiology. 2022 Jun 21:220220. doi: 10.1148/radiol.220220.
    PubMed     Abstract available


  25. GAO RZ, Sun WB, Gao J
    Percutaneous Sclerotherapy with Bleomycin and Ethiodized Oil: Is It a Promising Treatment for Giant Liver Hemangioma?
    Radiology. 2022;303:E39.
    PubMed    


  26. RONOT M
    Performance of LI-RADS for the Noninvasive Diagnosis of HCC: Pathology Should Not Be the Only Acceptable Reference.
    Radiology. 2022;303:546-547.
    PubMed    


    May 2022
  27. KHANNA G, Alazraki AL
    Quantitative US versus Quantitative MRI in the Assessment of Pediatric Chronic Liver Disease.
    Radiology. 2022 May 24:221066. doi: 10.1148/radiol.221066.
    PubMed    


  28. ALVES VPV, Dillman JR, Tkach JA, Bennett PS, et al
    Comparison of Quantitative Liver US and MRI in Patients with Liver Disease.
    Radiology. 2022 May 24:212995. doi: 10.1148/radiol.212995.
    PubMed     Abstract available


  29. RAMAN AG, Jones C, Weiss CR
    Machine Learning for Hepatocellular Carcinoma Segmentation at MRI: Radiology In Training.
    Radiology. 2022 May 10:212386. doi: 10.1148/radiol.212386.
    PubMed     Abstract available


  30. MIAO X, Sha T, Zhang W, Zhou H, et al
    Liver Fibrosis Assessment by Viewing Sinusoidal Capillarization: US Molecular Imaging versus Two-dimensional Shear-Wave Elastography in Rats.
    Radiology. 2022 May 3:212325. doi: 10.1148/radiol.212325.
    PubMed     Abstract available


    April 2022
  31. BORDE T, Nezami N, Gaupp FL, Savic LJ, et al
    Optimization of the BCLC Staging System for Locoregional Therapy for Hepatocellular Carcinoma by Using Quantitative Tumor Burden Imaging Biomarkers at MRI.
    Radiology. 2022 Apr 12:212426. doi: 10.1148/radiol.212426.
    PubMed     Abstract available


  32. WHITE SB
    The Immune Response: A New Frontier in Interventional Oncology.
    Radiology. 2022;303:229-230.
    PubMed    


  33. ATRI M, Jang HJ, Kim TK, Khalili K, et al
    Contrast-enhanced US of the Liver and Kidney: A Problem-solving Modality.
    Radiology. 2022;303:11-25.
    PubMed     Abstract available


  34. KENNEDY P, Marron TU, Taouli B
    Is There an Impact of Locoregional Therapy on Immune Response Modulation in HCC?
    Radiology. 2022;303:226-228.
    PubMed    


    March 2022
  35. ITO K
    US-derived Fat Fraction Screening of Hepatic Steatosis.
    Radiology. 2022 Mar 29:213052. doi: 10.1148/radiol.213052.
    PubMed    


  36. JUNG J, Han A, Madamba E, Bettencourt R, et al
    Direct Comparison of Quantitative US versus Controlled Attenuation Parameter for Liver Fat Assessment Using MRI Proton Density Fat Fraction as the Reference Standard in Patients Suspected of Having NAFLD.
    Radiology. 2022 Mar 29:211131. doi: 10.1148/radiol.211131.
    PubMed     Abstract available


  37. LEE JT
    Sarcopenia at Abdominal CT in Patients with Cirrhosis.
    Radiology. 2022 Mar 15:220191. doi: 10.1148/radiol.220191.
    PubMed    


  38. ZAFAR F, Lubert AM, Trout AT, Katz DA, et al
    Abdominal CT and MRI Findings of Portal Hypertension in Children and Adults with Fontan Circulation.
    Radiology. 2022 Mar 15:211037. doi: 10.1148/radiol.211037.
    PubMed     Abstract available


  39. LIU J, Ma J, Yang C, Chen M, et al
    Sarcopenia in Patients with Cirrhosis after Transjugular Intrahepatic Portosystemic Shunt Placement.
    Radiology. 2022 Mar 15:211172. doi: 10.1148/radiol.211172.
    PubMed     Abstract available


  40. DHONDT E, Lambert B, Hermie L, Huyck L, et al
    (90)Y Radioembolization versus Drug-eluting Bead Chemoembolization for Unresectable Hepatocellular Carcinoma: Results from the TRACE Phase II Randomized Controlled Trial.
    Radiology. 2022 Mar 8:211806. doi: 10.1148/radiol.211806.
    PubMed     Abstract available


  41. VAN DER POL CB, McInnes MDF, Salameh JP, Chernyak V, et al
    Impact of Reference Standard on CT, MRI, and Contrast-enhanced US LI-RADS Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis.
    Radiology. 2022 Mar 1:212340. doi: 10.1148/radiol.212340.
    PubMed     Abstract available


  42. DUAN L, Zhang BH, Zheng XH
    No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma.
    Radiology. 2022 Mar 1:211994. doi: 10.1148/radiol.211994.
    PubMed    


    February 2022
  43. CHUNG JW
    Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in the Era of New Systemic Agents.
    Radiology. 2022 Feb 1:212826. doi: 10.1148/radiol.212826.
    PubMed    


  44. ZHENG K, Zhu X, Fu S, Cao G, et al
    Sorafenib Plus Hepatic Arterial Infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized Trial.
    Radiology. 2022 Feb 1:211545. doi: 10.1148/radiol.211545.
    PubMed     Abstract available


    January 2022
  45. FERRAIOLI G, Kumar V, Ozturk A, Nam K, et al
    US Attenuation for Liver Fat Quantification: An AIUM-RSNA QIBA Pulse-Echo Quantitative Ultrasound Initiative.
    Radiology. 2022 Jan 25:210736. doi: 10.1148/radiol.210736.
    PubMed     Abstract available


  46. TISCHFIELD DJ, Gurevich A, Johnson O, Gatmaytan I, et al
    Transarterial Embolization Modulates the Immune Response within Target and Nontarget Hepatocellular Carcinomas in a Rat Model.
    Radiology. 2022 Jan 11:211028. doi: 10.1148/radiol.211028.
    PubMed     Abstract available


  47. JENSEN CT, Gupta S, Saleh MM, Liu X, et al
    Reduced-Dose Deep Learning Reconstruction for Abdominal CT of Liver Metastases.
    Radiology. 2022 Jan 11:211838. doi: 10.1148/radiol.211838.
    PubMed     Abstract available


    December 2021
  48. LOCKHART ME
    NASH Diagnosis Made Better but Maybe Not Yet Easier.
    Radiology. 2021;301:635-636.
    PubMed    


  49. SUGIMOTO K, Lee DH, Lee JY, Yu SJ, et al
    Multiparametric US for Identifying Patients with High-Risk NASH: A Derivation and Validation Study.
    Radiology. 2021;301:625-634.
    PubMed     Abstract available


    November 2021
  50. VAN DER POL CB, McInnes MDF, Salameh JP, Levis B, et al
    CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis.
    Radiology. 2021 Nov 16:211244. doi: 10.1148/radiol.2021211244.
    PubMed     Abstract available


  51. MARTI-AGUADO D, Jimenez-Pastor A, Alberich-Bayarri A, Rodriguez-Ortega A, et al
    Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease.
    Radiology. 2021 Nov 16:211027. doi: 10.1148/radiol.2021211027.
    PubMed     Abstract available


  52. DING PX, Lee EW
    Spontaneous Portosystemic Shunt with Budd-Chiari Syndrome.
    Radiology. 2021;301:282.
    PubMed     Abstract available


  53. AYOOBI YAZDI N, Mehrabinejad MM, Dashti H, Pourghorban R, et al
    Percutaneous Sclerotherapy with Bleomycin and Ethiodized Oil: A Promising Treatment in Symptomatic Giant Liver Hemangioma.
    Radiology. 2021;301:464-471.
    PubMed     Abstract available


    October 2021
  54. PEREZ AA, Noe-Kim V, Lubner MG, Graffy PM, et al
    Deep Learning CT-based Quantitative Visualization Tool for Liver Volume Estimation: Defining Normal and Hepatomegaly.
    Radiology. 2021 Oct 26:210531. doi: 10.1148/radiol.2021210531.
    PubMed     Abstract available


  55. REEDER SB
    Emergence of 3D MR Elastography-based Quantitative Markers for Diffuse Liver Disease.
    Radiology. 2021;301:163-165.
    PubMed    


  56. SOULEN MC, Garcia-Monaco R
    Closing the Gap in Curative Ablation of Liver Cancer.
    Radiology. 2021;301:237-238.
    PubMed    


    September 2021
  57. MORRELL GR
    Detection of Tumor Thrombus in Hepatocellular Carcinoma.
    Radiology. 2021 Sep 28:211984. doi: 10.1148/radiol.2021211984.
    PubMed    


  58. BAE JS, Lee JM, Jeon SK, Yoo J, et al
    LI-RADS Tumor in Vein at CT and Hepatobiliary MRI.
    Radiology. 2021 Sep 28:210215. doi: 10.1148/radiol.2021210215.
    PubMed     Abstract available


  59. YU MM, Tang XL, Jin H, Yang S, et al
    Coronary CT Angiography in Asymptomatic Adults with Hepatic Steatosis.
    Radiology. 2021 Sep 21:210355. doi: 10.1148/radiol.2021210355.
    PubMed     Abstract available


  60. STAREKOVA J, Hernando D, Pickhardt PJ, Reeder SB, et al
    Quantification of Liver Fat Content with CT and MRI: State of the Art.
    Radiology. 2021 Sep 21:204288. doi: 10.1148/radiol.2021204288.
    PubMed     Abstract available


    August 2021
  61. ZHANG T, Zhang G, Deng X, Zeng J, et al
    APS (Age, Platelets, 2D Shear-Wave Elastography) Score Predicts Hepatocellular Carcinoma in Chronic Hepatitis B.
    Radiology. 2021 Aug 24:204700. doi: 10.1148/radiol.2021204700.
    PubMed     Abstract available


  62. SHI Y, Qi YF, Lan GY, Wu Q, et al
    Three-dimensional MR Elastography Depicts Liver Inflammation, Fibrosis, and Portal Hypertension in Chronic Hepatitis B or C.
    Radiology. 2021 Aug 10:202804. doi: 10.1148/radiol.2021202804.
    PubMed     Abstract available


    July 2021
  63. LEE DH, Lee MW, Kim PN, Lee YJ, et al
    Outcome of No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Multicenter Clinical Trial.
    Radiology. 2021 Jul 27:210309. doi: 10.1148/radiol.2021210309.
    PubMed     Abstract available


  64. HE KS, Fernando R, Cabrera T, Valenti D, et al
    Hepatic Hilar Nerve Block for Hepatic Interventions: Anatomy, Technique, and Initial Clinical Experience in Thermal Ablation of Liver Tumors.
    Radiology. 2021 Jul 13:203410. doi: 10.1148/radiol.2021203410.
    PubMed     Abstract available


  65. KRINSKY G, Shanbhogue K
    Proliferative versus Nonproliferative Hepatocellular Carcinoma: Clinical and Imaging Implications.
    Radiology. 2021 Jul 6:211316. doi: 10.1148/radiol.2021211316.
    PubMed    


  66. KANG HJ, Kim H, Lee DH, Hur BY, et al
    Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery.
    Radiology. 2021 Jul 6:204352. doi: 10.1148/radiol.2021204352.
    PubMed     Abstract available


    June 2021
  67. JIANG H, Chen HC, Lafata KJ, Bashir MR, et al
    Week 4 Liver Fat Reduction on MRI as an Early Predictor of Treatment Response in Participants with Nonalcoholic Steatohepatitis.
    Radiology. 2021 Jun 1:204325. doi: 10.1148/radiol.2021204325.
    PubMed     Abstract available


  68. DU J, Bydder GM
    Brain Atrophy Is a Better Biomarker than Susceptibility for Evaluating Clinical Severity in Wilson Disease.
    Radiology. 2021;299:673-674.
    PubMed    


    May 2021
  69. BAI XM, Cui M, Yang W, Wang H, et al
    The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Radiology. 2021 May 18:200153. doi: 10.1148/radiol.2021200153.
    PubMed     Abstract available


  70. YOON JH, Kim H
    CT Characterization of Aggressive Macrotrabecular-Massive Hepatocellular Carcinoma: A Step Forward to Personalized Medicine.
    Radiology. 2021 May 11:210379. doi: 10.1148/radiol.2021210379.
    PubMed    


  71. FENG Z, Li H, Zhao H, Jiang Y, et al
    Preoperative CT for Characterization of Aggressive Macrotrabecular-Massive Subtype and Vessels That Encapsulate Tumor Clusters Pattern in Hepatocellular Carcinoma.
    Radiology. 2021 May 11:203614. doi: 10.1148/radiol.2021203614.
    PubMed     Abstract available


  72. MEIJERINK MR, Ruarus AH, Vroomen LGPH, Puijk RS, et al
    Irreversible Electroporation to Treat Unresectable Colorectal Liver Metastases (COLDFIRE-2): A Phase II, Two-Center, Single-Arm Clinical Trial.
    Radiology. 2021;299:470-480.
    PubMed     Abstract available


    April 2021
  73. PAISANT A, Gillard M, Oberti F, Roux M, et al
    Validation of a Diagnostic Algorithm for Hepatocellular Carcinoma at Gadoxetic Acid-enhanced MRI.
    Radiology. 2021 Apr 27:204529. doi: 10.1148/radiol.2021204529.
    PubMed     Abstract available


  74. LV J, Xu Y, Xu L, Nie L, et al
    Quantitative Functional Evaluation of Liver Fibrosis in Mice with Dynamic Contrast-enhanced Photoacoustic Imaging.
    Radiology. 2021 Apr 27:204134. doi: 10.1148/radiol.2021204134.
    PubMed     Abstract available


  75. LUZ JHM, Veloso Gomes F, Costa NV, Vasco I, et al
    BestFLR Trial: Liver Regeneration at CT before Major Hepatectomies for Liver Cancer-A Randomized Controlled Trial Comparing Portal Vein Embolization with N-Butyl-Cyanoacrylate Plus Iodized Oil versus Polyvinyl Alcohol Particles Plus Coils.
    Radiology. 2021 Apr 6:204055. doi: 10.1148/radiol.2021204055.
    PubMed     Abstract available


    March 2021
  76. DUSEK P, Lescinskij A, Ruzicka F, Acosta-Cabronero J, et al
    Associations of Brain Atrophy and Cerebral Iron Accumulation at MRI with Clinical Severity in Wilson Disease.
    Radiology. 2021 Mar 23:202846. doi: 10.1148/radiol.2021202846.
    PubMed     Abstract available


  77. BASHIR MR, Mendiratta-Lala M
    CT versus MRI in Treatment Response Assessment with LI-RADS: The Choice Is Unclear.
    Radiology. 2021 Mar 2:210049. doi: 10.1148/radiol.2021210049.
    PubMed    


    February 2021
  78. REEDER SB
    Portosystemic Shunts: Should We Pay Closer Attention with Cross-Sectional Imaging?
    Radiology. 2021 Feb 2:204282. doi: 10.1148/radiol.2021204282.
    PubMed    


    January 2021
  79. HU HH, Yokoo T, Bashir MR, Sirlin CB, et al
    Linearity and Bias of Proton Density Fat Fraction as a Quantitative Imaging Biomarker: A Multicenter, Multiplatform, Multivendor Phantom Study.
    Radiology. 2021 Jan 19:202912. doi: 10.1148/radiol.2021202912.
    PubMed     Abstract available


  80. CHANDARANA H, Shanbhogue K
    Noninvasive Staging of Liver Fibrosis with Dual-Energy CT: Close but No Cigar.
    Radiology. 2021 Jan 5:204315. doi: 10.1148/radiol.2021204315.
    PubMed    


  81. MARRI UK, Das P, Shalimar, Kalaivani M, et al
    Noninvasive Staging of Liver Fibrosis Using 5-Minute Delayed Dual-Energy CT: Comparison with US Elastography and Correlation with Histologic Findings.
    Radiology. 2021 Jan 5:202232. doi: 10.1148/radiol.2021202232.
    PubMed     Abstract available


  82. KIESSLING F
    US Microbubbles as Smart Sensors of Portal Venous Pressure.
    Radiology. 2021;298:112-113.
    PubMed    


  83. HAN K, Kim JH, Yang SG, Park SH, et al
    A Single-Center Retrospective Analysis of Periprocedural Variables Affecting Local Tumor Progression after Radiofrequency Ablation of Colorectal Cancer Liver Metastases.
    Radiology. 2021;298:212-218.
    PubMed     Abstract available


  84. KANG TW, Jeong WK, Kim YY, Min JH, et al
    Comparison of Super-Resolution US and Contrast Material-enhanced US in Detection of the Spoke Wheel Sign in Patients with Focal Nodular Hyperplasia.
    Radiology. 2021;298:82-90.
    PubMed     Abstract available


    November 2020
  85. SOULEN MC, Sofocleous CT
    Achieving Curative Ablation Outcomes: It Is All about the Imaging.
    Radiology. 2020 Nov 10:203930. doi: 10.1148/radiol.2020203930.
    PubMed    


    October 2020
  86. FETZER DT
    Recent Advances in US Vascular Imaging: Highlighting an Important Use Case.
    Radiology. 2020 Oct 27:203830. doi: 10.1148/radiol.2020203830.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: